Digital disruption and increased consumer expectation continue to create opportunities and risks for this rapidly evolving industry.
The patient is becoming a consumer of healthcare
Patients have more influence and buying power on their health services and therapies than ever before. Product-based companies are left with no choice, they must move closer to the patient care continuum. Failure to do so will impact business performance. To rise to this new set of challenges, leaders must disrupt, change their delivery models and develop new digital experiences for their patients.
Bold decisions
From the small biotechs to the large multinational pharmaceutical companies, bold investments and courageous decisions mean that large scale transformation projects are being undertaken across the entire value chain, rather than component parts.
To successfully transform, and to narrow the consumer and patient divide, leaders need to look at, and reshape, their operating models and rethink how to best serve their patients. They need to have access to the right digital eco-system, start with Cloud first and invest in transformative technologies. They must also consider their risk, growth and innovation agendas.
KPMG and Microsoft are helping organizations to accelerate their large-scale transformation programs.
